PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Powiadomienia systemowe
  • Sesja wygasła!
Tytuł artykułu

Stability-indicating RP-HPLC method for analysis of telmisartan in the bulk drug and in formulations

Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
A sensitive and reproducible HPLC method has been developed for quantitative analysis of telmisartan. The drug was separated from its degradation products on a C 18 column at ambient temperature with methanol-water 80:20 ( v / v ), pH 4.0 (adjusted by addition of orthophosphoric acid), as mobile phase at a flow rate of 1.0 mL min -1. Under these conditions the retention time of telmisartan was 4.85 ± 0.05 min. Quantification on the basis of peak area was achieved by UV detection at 225 nm; calibration plots were linear in the concentration range 10–60 μg mL -1 When the method was applied to a pharmaceutical formulation there was no chromatographic interference from tablet excipients. The method was validated for precision, robustness, recovery, and limits of detection and quantification. The drug was subjected to acidic and alkaline hydrolysis, and oxidising, dry heat, wet heat, and photodegrading conditions. Because the method could effectively separate the drug from its degradation products, it can be regarded as stability indicating.
Słowa kluczowe
Rocznik
Strony
539--548
Opis fizyczny
Bibliogr. 14 poz., rys., tab.
Twórcy
autor
  • Sinhgad College of Pharmacy Department of Pharmaceutical Chemistry Vadgaon, Pune 411041 India
autor
  • Bharati Vidyapeeth Deemed University, Poona College of Pharmacy Department of Quality Assurance Techniques Erandwane, Pune 411038 Maharashtra State India
autor
  • Bharati Vidyapeeth Deemed University, Poona College of Pharmacy Department of Quality Assurance Techniques Erandwane, Pune 411038 Maharashtra State India
  • Bharati Vidyapeeth Deemed University, Poona College of Pharmacy Department of Quality Assurance Techniques Erandwane, Pune 411038 Maharashtra State India
Bibliografia
  • [1] J.M. Neutel and D.H. Smith, Adv. Ther., 15 , 206 (1998)
  • [2] S. Hillaert and W. Van den Bossche, J. Pharm. Biomed. Anal., 31 , 329, (2003)
  • [3] S. Hillaert, T.R.M. De Beer, J.O. De Beer, and W. Van den Bossche, J. Chromatogr. A, 984, 135 (2003)
  • [4] M. Xu, J. Song, and Y. Liang, J. Pharm. Biomed. Anal., 34 , 681 (2004)
  • [5] M.S. Palled, P.M.N. Rajesh, and M. Chatter, AR Bhat, IJPS, 67 , 108 (2005)
  • [6] N. Torrealday, L. Gonzalez, R.M. Alonso, R.M. Jimenz, and E. Ortiz Lastra, J. Pharm. Biomed. Anal., 32 , 847 (2003)
  • [7] B. Chen, Y. Liang, Y. Wang, F. Deng, P. Zhou, F. Guo, and L. Haung, Anal. Chim. Acta, 540 , 367 (2005)
  • [8] P. Li, Y. Wang, Y. Wang, Y. Tang, J. Paul Fawcett, Y. Cui, and J. Gu, J. Chromatogr. B, 828 , 126 (2005)
  • [9] C. Hempen, L. Gläsle-Schwarz, U. Kunz, and U. Karst, Anal. Chim. Acta, 560 , 35 (2006)
  • [10] C. Hempen, L. Gläsle-Schwarz, U. Kunz, and U. Karst, Anal. Chim. Acta, 560 , 41 (2006)
  • [11] ICH, Q1A Stability Testing of New Drug Substances and Products, in: Proceedings of the International Conference on Harmonization, Geneva, October, 1993
  • [12] ICH, Q2A, Harmonised Tripartite Guideline, Text on Validation of Analytical Procedures, IFPMA, in: Proceedings of the International Conference on Harmonization, Geneva, March, 1994
  • [13] ICH, Q2B, Harmonised Tripartite Guideline, Validation of Analytical Procedure: Methodology, IFPMA, in: Proceedings of the International Conference on Harmonization, Geneva, March, 1996
  • [14] ICH Guidance on Analytical Method Validation, in: Proceedings of the International Convention on Quality for the Pharmaceutical Industry, Toronto, Canada, September, 2002
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-ac977cd2-5667-4d27-a319-750d4b320b7d
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.